Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2019 | 1 |
2021 | 1 |
2022 | 2 |
2023 | 1 |
2024 | 1 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Silibinin is a suppressor of the metastasis-promoting transcription factor ID3.
Phytomedicine. 2024 Mar 6;128:155493. doi: 10.1016/j.phymed.2024.155493. Online ahead of print.
Phytomedicine. 2024.
PMID: 38484626
Free article.
Addendum: Immune-related adverse events and atypical radiological response with checkpoint inhibitor immunotherapy in an elderly patient with high PD-L1 expressing lung adenocarcinoma.
Teixidor E, Sais E, Vásquez CA, Carbajal W, Hernández A, Sánchez G, Izquierdo A, Verdura S, Menéndez JA, Bosch-Barrera J.
Teixidor E, et al.
Oncotarget. 2023 Jul 1;14:668. doi: 10.18632/oncotarget.28471.
Oncotarget. 2023.
PMID: 37395727
Free PMC article.
No abstract available.
Item in Clipboard
Silibinin Overcomes EMT-Driven Lung Cancer Resistance to New-Generation ALK Inhibitors.
Verdura S, Encinar JA, Teixidor E, Segura-Carretero A, Micol V, Cuyàs E, Bosch-Barrera J, Menendez JA.
Verdura S, et al. Among authors: teixidor e.
Cancers (Basel). 2022 Dec 11;14(24):6101. doi: 10.3390/cancers14246101.
Cancers (Basel). 2022.
PMID: 36551587
Free PMC article.
Item in Clipboard
Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism.
Monteiro C, Miarka L, Perea-García M, Priego N, García-Gómez P, Álvaro-Espinosa L, de Pablos-Aragoneses A, Yebra N, Retana D, Baena P, Fustero-Torre C, Graña-Castro O, Troulé K, Caleiras E, Tezanos P, Muela P, Cintado E, Trejo JL, Sepúlveda JM, González-León P, Jiménez-Roldán L, Moreno LM, Esteban O, Pérez-Núñez Á, Hernández-Lain A, Mazarico Gallego J, Ferrer I, Suárez R, Garrido-Martín EM, Paz-Ares L, Dalmasso C, Cohen-Jonathan Moyal E, Siegfried A, Hegarty A, Keelan S, Varešlija D, Young LS, Mohme M, Goy Y, Wikman H, Fernández-Alén J, Blasco G, Alcázar L, Cabañuz C, Grivennikov SI, Ianus A, Shemesh N, Faria CC, Lee R, Lorigan P, Le Rhun E, Weller M, Soffietti R, Bertero L, Ricardi U, Bosch-Barrera J, Sais E, Teixidor E, Hernández-Martínez A, Calvo A, Aristu J, Martin SM, Gonzalez A, Adler O, Erez N; RENACER; Valiente M.
Monteiro C, et al. Among authors: teixidor e.
Nat Med. 2022 Apr;28(4):752-765. doi: 10.1038/s41591-022-01749-8. Epub 2022 Apr 11.
Nat Med. 2022.
PMID: 35411077
Free PMC article.
Item in Clipboard
Clinical Management of COVID-19 in Cancer Patients with the STAT3 Inhibitor Silibinin.
Bosch-Barrera J, Roqué A, Teixidor E, Carmona-Garcia MC, Arbusà A, Brunet J, Martin-Castillo B, Cuyàs E, Verdura S, Menendez JA.
Bosch-Barrera J, et al. Among authors: teixidor e.
Pharmaceuticals (Basel). 2021 Dec 24;15(1):19. doi: 10.3390/ph15010019.
Pharmaceuticals (Basel). 2021.
PMID: 35056076
Free PMC article.
Item in Clipboard
The dark side of immunotherapy: challenges facing the new hope in cancer treatment.
Teixidor E, Bosch-Barrera J.
Teixidor E, et al.
Ann Transl Med. 2019 Sep;7(Suppl 6):S183. doi: 10.21037/atm.2019.07.69.
Ann Transl Med. 2019.
PMID: 31656762
Free PMC article.
No abstract available.
Item in Clipboard
Immune-related adverse events and atypical radiological response with checkpoint inhibitor immunotherapy in an elderly patient with high PD-L1 expressing lung adenocarcinoma.
Teixidor E, Sais E, Vásquez CA, Carbajal W, Hernández A, Sánchez G, Izquierdo A, Verdura S, Menéndez JA, Bosch-Barrera J.
Teixidor E, et al.
Oncotarget. 2018 Aug 31;9(68):33043-33049. doi: 10.18632/oncotarget.25984. eCollection 2018 Aug 31.
Oncotarget. 2018.
PMID: 30250648
Free PMC article.
Item in Clipboard
Cite
Cite